https://www.selleckchem.com/pr....oducts/hg-9-91-01.ht
To evaluate the safety and efficacy of an at-home photobiomodulation (PBM) device for the treatment of diabetic foot ulcers (DFUs) in a frail population with severe comorbidities. Prospective, randomized, double-blind, sham-controlled pilot study. Patients (age = 63 ± 11years, malefemale 137) with insulin-dependent diabetes type 2, neuropathy, peripheral artery disease, significant co-morbidities, and large osteomyelitis-associated DFUs (University of Texas grade ≥ III) were randomized to receive active (n = 1 or sham (n = 1 at-h
Like
Comment
Share
